Pulmonary Tissue Collection
ProcedurePulmonary Tissue Collection
NCT Number: NCT04068389
The objective of this study is to evaluate the transplacental passage of fine and ultrafine particles (nanoparticles) inhaled by the mother.
Looking for future studies?
Notify MeFemale
Observational
Epidemiological studies have demonstrated the harmful effects of particulate air pollution on the progress of pregnancy and postnatal health.
Experimental studies have suggested the transplacental passage of asbestos fibers, but despite the strong growth in the use and production of fine and ultrafine particles, no study has examined the permeability of the placenta to these compounds or the exposures fetuses that may result.
The objective of this study is to evaluate the transplacental passage of fine and ultrafine particles (nanoparticles) inhaled by the mother.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pulmonary Tissue Collection
Time frame: At the screening
Analysis in electron microscopy
University Hospital, Bordeaux
Other
Study of the Permeability of Atmospheric Particles Placenta (Fine and Ultrafine Particles): Analysis of Fetal Retention
Acronym: FOETOPUF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06958458
Behavior, Empowerment
Yalova, Turkey (Türkiye)
View Trial DetailsNCT05520359
Brain Damage, Chronic, Brain Diseases
Seattle, Washington, United States
View Trial DetailsNCT02738411
Female Urogenital Diseases and Pregnancy Complications, Infant, Premature
Montpellier, France
View Trial DetailsNCT04154423
Anxiety Disorders, Behavior
Fresno, California, United States
View Trial Details